Effects of Arginine-Based Supplements on the Physical Working Capacity at the Fatigue Threshold

Camic, CL, Housh, TJ, Zuniga, JM, Hendrix, CR, Mielke, M, Johnson, GO, and Schmidt, RJ. Effects of arginine-based supplements on the physical working capacity at the fatigue threshold. J Strength Cond Res 24(5): 1306-1312, 2010-The purpose of the present study was to examine the effects of daily oral administration of arginine-based supplements for 4 weeks on the physical working capacity at the fatigue threshold (PWCFT). The PWCFT test is an electromyographic (EMG) procedure for estimating the highest power output that can be maintained without neuromuscular evidence of fatigue. The study used a double-blind, placebo-controlled design. Fifty college-aged men (mean age ± SD = 23.9 ± 3.0) were randomized into 1 of 3 groups: (a) placebo (n = 19); (b) 1.5 g arginine (n = 14); or (c) 3.0 g arginine (n = 17). The placebo was microcrystalline cellulose. The 1.5-g arginine group ingested 1.5 g of arginine and 300 mg of grape seed extract, whereas the 3.0 g arginine group ingested 3.0 g of arginine and 300 mg of grape seed extract. All subjects performed an incremental test to exhaustion on a cycle ergometer to determine their PWCFT before supplementation (PRE) and after 4 weeks of supplementation (POST). Surface EMG signals were recorded from the vastus lateralis using a bipolar electrode arrangement during the incremental tests for the determination of the PRE and POST supplementation PWCFT values. There were significant mean increases (PRE to POST) in PWCFT for the 1.5 g (22.4%) and 3.0 g (18.8%) supplement groups, but no change for the placebo group (−1.6%). These findings supported the use of arginine-based supplements, at the dosages examined in the present investigation, as an ergogenic aid for untrained individuals.

[1]  G. Keren,et al.  Improvement of cardiac performance by intravenous infusion of L-arginine in patients with moderate congestive heart failure. , 1995, Journal of the American College of Cardiology.

[2]  S. Bode-Böger,et al.  The clinical pharmacology of L-arginine. , 2001, Annual review of pharmacology and toxicology.

[3]  S. Doutreleau,et al.  L-Arginine Reduces Exercise-Induced Increase in Plasma Lactate and Ammonia , 2002, International journal of sports medicine.

[4]  T. Rector,et al.  Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. , 1996, Circulation.

[5]  L. Lindstrom,et al.  Muscular fatigue and action potential conduction velocity changes studied with frequency analysis of EMG signals. , 1970, Electromyography.

[6]  Travis W. Beck,et al.  The effects of innervation zone on electromyographic amplitude and mean power frequency during incremental cycle ergometry , 2006, Journal of Neuroscience Methods.

[7]  M. Uematsu,et al.  Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension. , 2001, American journal of respiratory and critical care medicine.

[8]  B. Campbell,et al.  The Ergogenic Potential of Arginine , 2004, Journal of the International Society of Sports Nutrition.

[9]  M. J. Hartman,et al.  Effects of Creatine Monohydrate and Polyethylene Glycosylated Creatine Supplementation on Muscular Strength, Endurance, and Power Output , 2009, Journal of strength and conditioning research.

[10]  L. Ceremużyński,et al.  Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris. , 1997, The American journal of cardiology.

[11]  Tsung-Han Liu,et al.  No effect of short-term arginine supplementation on nitric oxide production, metabolism and performance in intermittent exercise in athletes. , 2009, The Journal of nutritional biochemistry.

[12]  T Moritani,et al.  Electromyographic manifestations of muscular fatigue. , 1982, Medicine and science in sports and exercise.

[13]  R L Lieber,et al.  Clinical significance of skeletal muscle architecture. , 2001, Clinical orthopaedics and related research.

[14]  T. Kaminski,et al.  High-intensity dynamic human muscle performance enhanced by a metabolic intervention. , 2000, Medicine and science in sports and exercise.

[15]  T. Fukunaga,et al.  Determination of fascicle length and pennation in a contracting human muscle in vivo. , 1997, Journal of applied physiology.

[16]  B. Whipp,et al.  The maximally attainable VO2 during exercise in humans: the peak vs. maximum issue. , 2003, Journal of applied physiology.

[17]  D. Fitzpatrick,et al.  Vasodilating Procyanidins Derived from Grape Seeds , 2002, Annals of the New York Academy of Sciences.

[18]  B. Knechtle,et al.  Influence of chronic supplementation of arginine aspartate in endurance athletes on performance and substrate metabolism - a randomized, double-blind, placebo-controlled study. , 2005, International journal of sports medicine.

[19]  H. Devries,et al.  Neuromuscular fatigue thresholds of the vastus lateralis, vastus medialis and rectus femoris muscles. , 1996, Electromyography and clinical neurophysiology.

[20]  R. C. Bruce,et al.  Exercise‐induced changes in plasma potassium and the ventilatory threshold in man. , 1994, The Journal of physiology.

[21]  D. Tsikas,et al.  L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. , 1994, Clinical science.

[22]  C. Rasmussen,et al.  Pharmacokinetics, safety, and effects on exercise performance of L-arginine alpha-ketoglutarate in trained adult men. , 2006, Nutrition.

[23]  W. Buczko,et al.  L-arginine and cardiovascular system. , 2005, Pharmacological reports : PR.

[24]  G. Peck,et al.  Water Based Silicone Elastomer Controlled Release Tablet Film Coating III - Drug Release Mechanisms , 1989 .

[25]  S. Higano,et al.  Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. , 1998, Circulation.

[26]  P. Stone,et al.  Randomized trial of a medical food for the dietary management of chronic, stable angina. , 2002, Journal of the American College of Cardiology.

[27]  H. Hermens,et al.  European recommendations for surface electromyography: Results of the SENIAM Project , 1999 .

[28]  A. Koch,et al.  Glycine-Arginine--Ketoisocaproic Acid Improves Performance of Repeated Cycling Sprints , 2004 .

[29]  D. Fitzpatrick,et al.  Isolation and characterization of endothelium-dependent vasorelaxing compounds from grape seeds. , 2000, Journal of agricultural and food chemistry.

[30]  T Abe,et al.  Fascicle length of leg muscles is greater in sprinters than distance runners. , 2000, Medicine and science in sports and exercise.

[31]  H. Devries,et al.  Factors affecting the estimation of physical working capacity at the fatigue threshold. , 1990, Ergonomics.

[32]  D. Stewart,et al.  Short-term pulmonary vasodilation with L-arginine in pulmonary hypertension. , 1995, Circulation.

[33]  R. Wolfe,et al.  Potential ergogenic effects of arginine and creatine supplementation. , 2004, The Journal of nutrition.

[34]  B. Canny,et al.  L-Arginine infusion increases glucose clearance during prolonged exercise in humans. , 2006, American journal of physiology. Endocrinology and metabolism.

[35]  J. Bangsbo,et al.  Effect of muscle acidity on muscle metabolism and fatigue during intense exercise in man. , 1996, The Journal of physiology.

[36]  I Petersén,et al.  Conduction velocity in ischemic muscle: effect on EMG frequency spectrum. , 1970, The American journal of physiology.